Novo Nordisk CDR (CAD Hedged)

Healthcare CA NOVO

17.78CAD
-0.31(1.71%)

Last update at 2026-06-03T19:40:00Z

Day Range

17.6418.03

LowHigh

52 Week Range

14.5226.90

LowHigh

Fundamentals

Previous Close 18.09
Market Cap807698.00M
Volume7870
P/E Ratio3.31
Dividend Yield69.56%
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown

Breakdown

Breakdown

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - General

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
NOVO Novo Nordisk CDR (CAD Hedged)	-0.31 1.71%	17.78	3.31	3.54	1.10	1.74	3.88	7.66
MRK Merck CDR (CAD Hedged)	-0.04 0.15%	25.78	15.70	22.32	4.40	5.36	4.81	11.07
AMGN Amgen CDR (CAD Hedged)	0.62 2.53%	25.12	24.19	15.65	5.06	21.36	6.30	13.69
GILD Gilead Sciences CDR (CAD Hedged)	0.44 1.70%	26.29	19.51	15.04	5.62	7.21	6.14	13.31
SNY Sanofi CDR (CAD Hedged)	-0.13 0.68%	19.09	3.25	1.53	0.34	0.22	2.33	8.73

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.